default author photo

Li Xie

Shanghai Jiao Tong University (SJTU)

KoGuan Law School

Shanghai 200030, Shanghai 200052

China

SCHOLARLY PAPERS

1

DOWNLOADS

85

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Phase II Study of the Safety and Antitumour Activity of Apatinib in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck

Number of pages: 52 Posted: 28 Nov 2018
Guopei Zhu, Lin Zhang, Shengjin Dou, Rongrong Li, Li Xie, Jiang Li, Ziyang Shao, Min Ruan, Wenjun Yang, Jian Sun and Chenping Zhang
Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Jiao Tong University (SJTU), Shanghai Key Laboratory of Stomatology & Shanghai Research Institute of Stomatology, Shanghai Jiao Tong University (SJTU), Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology and Shanghai Jiao Tong University (SJTU) - Department of Oral and Maxillofacial-Head Neck Oncology
Downloads 85 (771,553)

Abstract:

Loading...

adrenocortical carcinoma, apatinib, Vascular endothelial growth factor, targeted therapy